Symptoms typically resolve with increased hydration and dietary fiber
Standard appeals typically require a response within 30 days
AOD 9604 peptide, also called the fat-burning peptide, is an anti-obesity drug (AOD) that can also be used for losing weight for non-obese patients
In comparison, Mounjaros KwikPen ranges from Rs 14,000 (2.5 mg) to Rs 27,500 (15 mg)
Suitable for adults with a BMI of 30 or above or 27 and above with one weight-related condition, Wegovy showed an average weight loss of 15% in clinical trials
Wegovy and other GLP-1 receptor agonists have also been linked to an increased risk of acute pancreatitis, gallbladder problems, acute kidney injury, low blood sugar, diabetic retinopathy complications, increased heart rate, and suicidal thoughts